The Effect of Manuka Eye Drops on Tear Film Properties
NCT03622619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2021-05-18
Summary
Traditionally, Manuka honey has been used to combat against bacteria and reduce inflammation (the body's way of reacting to infection, irritation or other injury). Due to the inflammatory nature of dry eye, Manuka eye drops show promise as a treatment for dry eye disease. The aim of this research is to compare the effects of two over the counter eye drops that are used to treat dry eye conditions over a one month period.
Conditions
- Dry Eye Syndrome
Interventions
- OTHER
-
Optimel Antibacterial Manuka+ Dry Eye Drops
Leptospermum sp Honey 165mg/g
- OTHER
-
Systane Ultra Lubricating Eye Drops
Polyethylene glycol 400 0.4% and propylene glycol 0.3%
Sponsors & Collaborators
-
The University of New South Wales
lead OTHER
Principal Investigators
-
Jacqueline Tan, PhD · University of New South Wales
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-13
- Primary Completion
- 2018-10-30
- Completion
- 2018-10-30
Countries
- Australia
Study Locations
More Related Trials
-
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Osmolarity Clinical Utility in Dry Eye Disease
NCT02417116 ·Status: COMPLETED ·Phase: NA
-
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825586 ·Status: COMPLETED ·Phase: NA
-
Effects of Topical Insulin on Levels of Tear Inflammatory Mediators
NCT04877210 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
NCT02871440 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
NCT03436576 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Autologous Blood Treatment for Ocular Surface Disease
NCT03659955 ·Status: COMPLETED ·Phase: NA
-
The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry Eye
NCT02160327 ·Status: UNKNOWN
-
Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye
NCT04521465 ·Status: COMPLETED
-
Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy
NCT07329712 ·Status: RECRUITING
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye
NCT02219204 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
Eye Mask on Sleep Quality and Tear Layer Function in Patients With Dry Eye Disease
NCT06016166 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
NCT00831662 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
NCT00600288 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Dry Eye Microbiome
NCT02306668 ·Status: UNKNOWN
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3